| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 147, 905-911, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
JJ Isola, OP Kallioniemi, LW Chu, SA Fuqua, SG Hilsenbeck, CK Osborne and FM Waldman
Department of Laboratory Medicine, University of California, San Francisco, USA.
Breast cancer progression is determined by a complex pattern of multiple genetic aberrations the association of which with patient prognosis is unknown. In this study, we have undertaken a genome-wide screening to detect genetic changes associated with clinical outcome in node-negative breast cancer. Comparative genomic hybridization was used to screen for DNA sequence gains and losses across all human chromosomes in 23 tumors from node-negative breast cancer patients with no disease recurrence after at least 5 years of follow-up and in 25 node-negative patients with recurrence during the first 5 years of follow-up. The total number of genetic aberrations (copy number gains and losses) per tumor was significantly greater in the recurrence group (P = 0.019) and in the subgroup of these patients who died as a result of breast cancer (P = 0.0022). When copy number losses and gains were analyzed separately, only losses were significant (P = 0.013 for recurrence and P = 0.002 for overall survival). Of the individual loci involved, a high level gain of the long arm of chromosome 8 was significantly associated with recurrence (P = 0.01, Fisher's exact test). Furthermore, amplification of DNA sequences at chromosome 20q12- 13 was found in 7 cases (15%), 6 of which had early recurrence within 32 months of diagnosis. This genome-wide overview by comparative genomic hybridization suggests that genetically advanced node-negative breast cancers having a high overall number of genetic aberrations may have a poor prognosis and that increased copy number of two specific regions, 8q and 20q13, may confer a more aggressive phenotype. Results of this pilot study suggest that determination of the total number of DNA sequence copy number aberrations may help therapeutic decision making. Specific probes should be developed to test the prognostic value of 8q and 20q12-13 amplifications in large numbers of patients.
This article has been cited by other articles:
 |
|
 |
|
  A. Rizki, V. M. Weaver, S.-Y. Lee, G. I. Rozenberg, K. Chin, C. A. Myers, J. L. Bascom, J. D. Mott, J. R. Semeiks, L. R. Grate, et al. A Human Breast Cell Model of Preinvasive to Invasive Transition Cancer Res., March 1, 2008; 68(5): 1378 - 1387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schleicher, C. Poremba, H. Wolters, K.-L. Schafer, N. Senninger, and M. Colombo-Benkmann Gain of Chromosome 8q: A Potential Prognostic Marker in Resectable Adenocarcinoma of the Pancreas? Ann. Surg. Oncol., April 1, 2007; 14(4): 1327 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dolled-Filhart, L. Ryden, M. Cregger, K. Jirstrom, M. Harigopal, R. L. Camp, and D. L. Rimm Classification of breast cancer using genetic algorithms and tissue microarrays. Clin. Cancer Res., November 1, 2006; 12(21): 6459 - 6468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A E Pinto, L Roque, R Rodrigues, S Andre, and J Soares Frequent 7q gains in flow cytometric multiploid/hypertetraploid breast carcinomas: a study of chromosome imbalances by comparative genomic hybridisation J. Clin. Pathol., April 1, 2006; 59(4): 367 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Stange, B. Radlwimmer, F. Schubert, F. Traub, A. Pich, G. Toedt, F. Mendrzyk, U. Lehmann, R. Eils, H. Kreipe, et al. High-Resolution Genomic Profiling Reveals Association of Chromosomal Aberrations on 1q and 16p with Histologic and Genetic Subgroups of Invasive Breast Cancer Clin. Cancer Res., January 15, 2006; 12(2): 345 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Packeisen, K Nakachi, W Boecker, B Brandt, and H Buerger Cytogenetic differences in breast cancer samples between German and Japanese patients J. Clin. Pathol., October 1, 2005; 58(10): 1101 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tanaka, Y. Hashimoto, T. Ito, T. Okumura, T. Kan, G. Watanabe, M. Imamura, J. Inazawa, and Y. Shimada The Clinical Significance of Aurora-A/STK15/BTAK Expression in Human Esophageal Squamous Cell Carcinoma Clin. Cancer Res., March 1, 2005; 11(5): 1827 - 1834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nessling, K. Richter, C. Schwaenen, P. Roerig, G. Wrobel, S. Wessendorf, B. Fritz, M. Bentz, H.-P. Sinn, B. Radlwimmer, et al. Candidate Genes in Breast Cancer Revealed by Microarray-Based Comparative Genomic Hybridization of Archived Tissue Cancer Res., January 15, 2005; 65(2): 439 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W. M. Loo, D. I. Grove, E. M. Williams, C. L. Neal, L. A. Cousens, E. L. Schubert, I. N. Holcomb, H. F. Massa, J. Glogovac, C. I. Li, et al. Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes Cancer Res., December 1, 2004; 64(23): 8541 - 8549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Rennstam, M. Ahlstedt-Soini, B. Baldetorp, P.-O. Bendahl, A. Borg, R. Karhu, M. Tanner, M. Tirkkonen, and J. Isola Patterns of Chromosomal Imbalances Defines Subgroups of Breast Cancer with Distinct Clinical Features and Prognosis. A Study of 305 Tumors by Comparative Genomic Hybridization Cancer Res., December 15, 2003; 63(24): 8861 - 8868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dyer, E. Prebble, V. Davison, P. Davies, P. Ramani, D. Ellison, and R. Grundy Genomic Imbalances in Pediatric Intracranial Ependymomas Define Clinically Relevant Groups Am. J. Pathol., December 1, 2002; 161(6): 2133 - 2141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Climent, J. A. Martinez-Climent, D. Blesa, M. J. Garcia-Barchino, R. Saez, D. Sanchez-Izquierdo, P. Azagra, A. Lluch, and J. Garcia-Conde Genomic Loss of 18p Predicts an Adverse Clinical Outcome in Patients with High-Risk Breast Cancer Clin. Cancer Res., December 1, 2002; 8(12): 3863 - 3869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Moore, A. H. Smith, C. Eng, D. Kalman, S. DeVries, V. Bhargava, K. Chew, D. Moore II, C. Ferreccio, O. A. Rey, et al. Arsenic-Related Chromosomal Alterations in Bladder Cancer J Natl Cancer Inst, November 20, 2002; 94(22): 1688 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dellas, J. Torhorst, E. Schultheiss, M. J. Mihatsch, and H. Moch DNA Sequence Losses on Chromosomes 11p and 18q Are Associated with Clinical Outcome in Lymph Node-negative Ductal Breast Cancer Clin. Cancer Res., May 1, 2002; 8(5): 1210 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Saramaki, N. Willi, O. Bratt, T. C. Gasser, P. Koivisto, N. N. Nupponen, L. Bubendorf, and T. Visakorpi Amplification of EIF3S3 Gene Is Associated with Advanced Stage in Prostate Cancer Am. J. Pathol., December 1, 2001; 159(6): 2089 - 2094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-M. Cleton-Jansen, D. F. Callen, R. Seshadri, S. Goldup, B. McCallum, J. Crawford, J. A. Powell, C. Settasatian, H. van Beerendonk, E. W. Moerland, et al. Loss of Heterozygosity Mapping at Chromosome Arm 16q in 712 Breast Tumors Reveals Factors that Influence Delineation of Candidate Regions Cancer Res., February 1, 2001; 61(3): 1171 - 1177. [Abstract] [Full Text]
|
|
|
|
|
|
G.-J. Wu, C. S. Sinclair, J. Paape, J. N. Ingle, P. C. Roche, C. D. James, and F. J. Couch 17q23 Amplifications in Breast Cancer Involve the PAT1, RAD51C, PS6K, and SIGMA1B Genes Cancer Res., October 1, 2000; 60(19): 5371 - 5375. [Abstract] [Full Text]
|
|
|
|
|
|
F. Forozan, E. H. Mahlamäki, O. Monni, Y. Chen, R. Veldman, Y. Jiang, G. C. Gooden, S. P. Ethier, A. Kallioniemi, and O.-P. Kallioniemi Comparative Genomic Hybridization Analysis of 38 Breast Cancer Cell Lines: A Basis for Interpreting Complementary DNA Microarray Data Cancer Res., August 1, 2000; 60(16): 4519 - 4525. [Abstract] [Full Text]
|
|
|
|
|
|
W.'e. El-Rifai, M. Sarlomo-Rikala, L. C. Andersson, S. Knuutila, and M. Miettinen DNA Sequence Copy Number Changes in Gastrointestinal Stromal Tumors: Tumor Progression and Prognostic Significance Cancer Res., July 1, 2000; 60(14): 3899 - 3903. [Abstract] [Full Text]
|
|
|
|
|
|
S. Hidaka, T. Yasutake, H. Takeshita, M. Kondo, T. Tsuji, A. Nanashima, T. Sawai, H. Yamaguchi, T. Nakagoe, H. Ayabe, et al. Differences in 20q13.2 Copy Number between Colorectal Cancers with and without Liver Metastasis Clin. Cancer Res., July 1, 2000; 6(7): 2712 - 2717. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. W. Gray and C. Collins Genome changes and gene expression in human solid tumors Carcinogenesis, March 1, 2000; 21(3): 443 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Waldman, S. DeVries, K. L. Chew, D. H. Moore II, K. Kerlikowske, and B.-M. Ljung Chromosomal Alterations in Ductal Carcinomas In Situ and Their In Situ Recurrences J Natl Cancer Inst, February 16, 2000; 92(4): 313 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Isola, L. Chu, S. DeVries, K. Matsumura, K. Chew, B. M. Ljung, and F. M. Waldman Genetic Alterations in ERBB2-amplified Breast Carcinomas Clin. Cancer Res., December 1, 1999; 5(12): 4140 - 4145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Richter, U. Wagner, P. Schraml, R. Maurer, G. Alund, H. Knonagel, H. Moch, M. J. Mihatsch, T. C. Gasser, and G. Sauter Chromosomal Imbalances Are Associated with a High Risk of Progression in Early Invasive (pT1) Urinary Bladder Cancer Cancer Res., November 1, 1999; 59(22): 5687 - 5691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhao, J. Richter, U. Wagner, B. Roth, P. Schraml, T. Zellweger, D. Ackermann, U. Schmid, H. Moch, M. J. Mihatsch, et al. Chromosomal Imbalances in Noninvasive Papillary Bladder Neoplasms (pTa) Cancer Res., September 1, 1999; 59(18): 4658 - 4661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Shivapurkar, S. Sood, I. I. Wistuba, A. K. Virmani, A. Maitra, S. Milchgrub, J. D. Minna, and A. F. Gazdar Multiple Regions of Chromosome 4 Demonstrating Allelic Losses in Breast Carcinomas Cancer Res., August 1, 1999; 59(15): 3576 - 3580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dellas, J. Torhorst, F. Jiang, J. Proffitt, E. Schultheiss, W. Holzgreve, G. Sauter, M. J. Mihatsch, and H. Moch Prognostic Value of Genomic Alterations in Invasive Cervical Squamous Cell Carcinoma of Clinical Stage IB Detected by Comparative Genomic Hybridization Cancer Res., July 1, 1999; 59(14): 3475 - 3479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Bissig, J. Richter, R. Desper, V. Meier, P. Schraml, A. A. Schaffer, G. Sauter, M. J. Mihatsch, and H. Moch Evaluation of the Clonal Relationship between Primary and Metastatic Renal Cell Carcinoma by Comparative Genomic Hybridization Am. J. Pathol., July 1, 1999; 155(1): 267 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. N. Nupponen, K. Porkka, L. Kakkola, M. Tanner, K. Persson, A. Borg, J. Isola, and T. Visakorpi Amplification and Overexpression of p40 Subunit of Eukaryotic Translation Initiation Factor 3 in Breast and Prostate Cancer Am. J. Pathol., June 1, 1999; 154(6): 1777 - 1783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tanaka, M. Kimura, K. Matsunaga, D. Fukada, H. Mori, and Y. Okano Centrosomal Kinase AIK1 Is Overexpressed in Invasive Ductal Carcinoma of the Breast Cancer Res., May 1, 1999; 59(9): 2041 - 2044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Roylance, P. Gorman, W. Harris, R. Liebmann, D. Barnes, A. Hanby, and D. Sheer Comparative Genomic Hybridization of Breast Tumors Stratified by Histological Grade Reveals New Insights into the Biological Progression of Breast Cancer Cancer Res., April 1, 1999; 59(7): 1433 - 1436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kimura, Y. Matsuda, T. Yoshioka, and Y. Okano Cell Cycle-dependent Expression and Centrosome Localization of a Third Human Aurora/Ipl1-related Protein Kinase, AIK3 J. Biol. Chem., March 12, 1999; 274(11): 7334 - 7340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Giet and C Prigent Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases J. Cell Sci., January 11, 1999; 112(21): 3591 - 3601. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Collins, J. M. Rommens, D. Kowbel, T. Godfrey, M. Tanner, S.-i. Hwang, D. Polikoff, G. Nonet, J. Cochran, K. Myambo, et al. Positional cloning of ZNF217 and NABC1: Genes amplified at 20q13.2 and overexpressed in breast carcinoma PNAS, July 21, 1998; 95(15): 8703 - 8708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. N. Nupponen, L. Kakkola, P. Koivisto, and T. Visakorpi Genetic Alterations in Hormone-Refractory Recurrent Prostate Carcinomas Am. J. Pathol., July 1, 1998; 153(1): 141 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Tanner, R. A. Karhu, N. N. Nupponen, A. Borg, B. Baldetorp, T. Pejovic, M. Ferno, D. Killander, and J. J. Isola Genetic Aberrations in Hypodiploid Breast Cancer : Frequent Loss of Chromosome 4 and Amplification of CyclinD1 Oncogene Am. J. Pathol., July 1, 1998; 153(1): 191 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zamostiano, A. Pinhasov, E. Gelber, R. A. Steingart, E. Seroussi, E. Giladi, M. Bassan, Y. Wollman, H. J. Eyre, J. C. Mulley, et al. Cloning and Characterization of the Human Activity-dependent Neuroprotective Protein J. Biol. Chem., January 5, 2001; 276(1): 708 - 714. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
